Wendong Lei

Statistics

Publications

Citations

709

H-Index

Active since

1998

Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College(Current)

National Cancer Center

Allegheny Health Network

Wendong Lei is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in oncology, medicine, and neoadjuvant therapy.

Publications per year

1998–2020

Publications

Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC

Shugeng Gao, Ning Li, Shun‐Yu Gao et al. · Journal of Thoracic Oncology · 2020 · 415 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Clinical characteristics and medical service utilization of lung cancer in China, 2005–2014: Overall design and results from a multicenter retrospective epidemiologic survey

Jufang Shi, Le Wang, Ning Wu et al. · Lung Cancer · 2018 · 134 citations

Medicine, Oncology, Cancer Control +15

Enhancement of chemosensitivity and programmed cell death by tyrosine kinase inhibitors correlates with EGFR expression in non-small cell lung cancer cells.

Wendong Lei, Jane Mayotte, M. L. Levitt · PubMed · 1999 · 64 citations

Medicine, Oncology, Pharmacology +16

Characteristics and prognosis of primary malignant melanoma of the esophagus

Baozhong Li, Wendong Lei, Kang Shao et al. · Melanoma Research · 2007 · 63 citations

Medicine, Oncology, Surgery +14

Efficacy and safety of neoadjuvant PD-1 blockade with sintilimab in resectable squamous non-small cell lung cancer (sqNSCLC).

Ning Li, Jianming Ying, Xiuli Tao et al. · Journal of Clinical Oncology · 2019 · 17 citations

Medicine, Oncology, Surgery +16

1–5 of 6